| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 9 |
| 1 | ACETAMINOPHEN | 5 |
| 2 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 5 |
| 3 | ADALIMUMAB | 5 |
| 4 | BUPRENORPHINE | 5 |
| 5 | DULOXETINE | 5 |
| 6 | DULOXETINE HYDROCHLORIDE | 5 |
| 7 | FOLIC ACID | 5 |
| 8 | METHOTREXATE | 5 |
| 9 | METHOTREXATE SODIUM | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRANDOLAPRIL TABLETS | 5 | 0.0025 |
| 1 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 4 | 0.0006 |
| 2 | MAGNESIUM CITRATE ORAL SOLUTION | 4 | 0.0006 |
| 3 | MAGNESIUM CITRATE | 4 | 0.0006 |
| 4 | ERGOCALCIFEROL | 9 | 0.0003 |
| 5 | IDURSULFASE | 1 | 0.0003 |
| 6 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 2 | 0.0002 |
| 7 | RIBOCICLIB | 4 | 0.0001 |
| 8 | FULVESTRANT | 4 | 0.0001 |
| 9 | OXYCODONE AND ACETAMINOPHEN | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 9 |
| 1 | Angiotensin Converting Enzyme Inhibitor [EPC] | 5 |
| 2 | Expectorant [EPC] | 5 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 5 |
| 4 | Interleukin-17A Antagonist [EPC] | 5 |
| 5 | Partial Opioid Agonist [EPC] | 5 |
| 6 | Vitamin B12 [EPC] | 5 |
| 7 | Vitamin C [EPC] | 5 |
| 8 | Vitamin D [EPC] | 5 |
| 9 | Aromatase Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 1 | Interleukin-17A Antagonist [EPC] | 5 | 0.0001 |
| 2 | Estrogen Receptor Antagonist [EPC] | 4 | 0.0001 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Partial Opioid Agonist [EPC] | 5 | 0.0001 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Aromatase Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Calcium [EPC] | 4 | 0.0000 |
| 8 | Expectorant [EPC] | 5 | 0.0000 |
| 9 | Vitamin D [EPC] | 5 | 0.0000 |